PTAB challenges

Based on the provided information and public records concerning US patent 12,112,357, here is an analysis of all AIA trial proceedings on file.

Proceedings overview

There has been one AIA trial proceeding filed against US patent 12,112,357. That proceeding, an Inter Partes Review (IPR), was discretionarily denied at the institution stage and did not proceed to a trial on the merits. This means the patent has survived its only PTAB challenge to date, but because the denial was procedural and not based on the substance of the prior art, the patent has not been "hardened" by the proceeding, and the petitioner is not estopped from re-asserting the same invalidity grounds in other venues.

---

IPR2026-00079 — Meta Platforms, LLC v. Weple IP Holdings LLC

• Type: Inter Partes Review
• Filed: 2025-10-31
• Status: Discretionary Denial. The Patent Trial and Appeal Board (PTAB) declined to institute a trial, meaning the case was dismissed before a formal review of the merits of the invalidity arguments could begin. This was a procedural denial, not a decision that the patent claims were valid over the asserted prior art.
• Judge panel: I do not have access to the specific judge panel for this proceeding. This information would be available in the papers filed for this case on the USPTO's PTAB E2E portal.
• Petition grounds: I do not have access to the specific claims challenged or the prior art asserted in the petition. This information would be detailed in the petition document, which is typically available on the USPTO's PTAB E2E portal for the corresponding proceeding number.
• Institution decision: The petition was denied institution on 2026-04-06. According to the provided patent data, the reason was procedural. These types of discretionary denials often occur when there is a co-pending district court litigation between the same parties concerning the same patent. Under the Fintiv framework, the PTAB may decline to institute an IPR if the parallel court case is sufficiently advanced, in order to avoid duplicative efforts and the potential for conflicting outcomes.
• Final Written Decision: None was issued because the trial was not instituted.
• Settlement / termination: The proceeding was terminated by the PTAB's denial of institution, not by a settlement between the parties.
• Appeal: A petitioner cannot appeal a non-institution decision to the Federal Circuit. Therefore, there was no appeal.
• Defensive value: This proceeding provides limited defensive value. While the patent survived, it was not tested on the merits. The specific prior art and arguments raised by Meta in its petition are publicly available and can be evaluated and potentially used by other defendants. Crucially, because institution was denied, the petitioner (Meta) and its privies are not subject to statutory estoppel under 35 U.S.C. § 315(e)(2), leaving them free to raise the same invalidity grounds again in district court.

Strategic summary

No claims of US patent 12,112,357 have been canceled or substantively validated by the PTAB. All 30 claims of the patent remain untested in an AIA trial. The sole IPR filed against the patent was terminated at the earliest possible stage due to a discretionary, procedural denial.

The estoppel landscape for this patent is currently clear. Because IPR2026-00079 was not instituted, no statutory estoppel applies. A defendant currently facing assertion of this patent, including Meta Platforms, is free to challenge the patent's validity in district court or at the PTAB using any available prior-art grounds, including those that may have been raised in the denied IPR petition.

The pattern of activity indicates that the patent is being asserted by a patent licensing entity (Weple IP Holdings LLC) against a major technology company (Meta), which is a common scenario for patent litigation. The fact that an IPR was filed and discretionarily denied suggests there is active, parallel district court litigation (as indicated by the reference to a case in the Western District of Washington in the patent data source). Defendants should investigate the status of that litigation, as it will likely inform the patent owner's strategy and timelines.

Recommended next steps

For a defendant facing a demand letter citing US patent 12,112,357, the key takeaway is that the patent's validity has not been confirmed by the USPTO in a contested proceeding.

• Review the IPR File Wrapper: The most critical next step is to obtain and analyze the complete file for IPR2026-00079 from the USPTO's PTAB E2E portal. The petition will detail Meta's invalidity arguments and the asserted prior art, providing a well-researched starting point for your own validity analysis.
• Analyze the Denial Decision: The Decision Denying Institution, likely issued on or around 2026-04-06, should be reviewed carefully. It will explain the specific procedural reasons for the denial. If it was a Fintiv-based denial, the decision will provide insight into the status of the parallel district court case, which is valuable intelligence.
• No Claims Invalidated: Be aware that the patent owner may characterize this outcome as a "win." You should be prepared to counter that a procedural, discretionary denial is not a decision on the merits and has no bearing on whether the claims are actually valid. No claims have been canceled.